Alzheimer Disease
Interim report for the first quarter of 2007
Published in Lab Law Weekly, June 1st, 2007
* First-quarter consolidated revenue amounted to DKK 2,583 million, a 16% increase relative to the year-earlier period (20% increase at CER).
* Revenue derived from Europe amounted to DKK 1,485 million, a 9% increase over the year-earlier period (11% growth at CER). Revenue from International Markets amounted to DKK 401 million, a 22% increase (33% growth at CER). Revenue from the USA amounted to DKK 631 million, a 29% increase (37% increase at CER).
* Profit from operations was DKK 658 million, a 46% rise relative...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2007-06-01)
More Articles from Lab Law Weekly
- AdvaMed
Advamed Commends Passage of FDA Revitalization Act - Advanced Magnetics, Inc.
Advanced Magnetics Announces Proposed Public Offering of Common Stock - Alliance HealthCard, Inc.
Alliance HealthCard 2Q Profit Rises 57 Percent - Alliance Imaging, Inc.
Alliance Imaging Announces Sale of Stock by a Stockholder - Alzheimer Disease
Shire welcomes early date for Judicial Review of NICE decision on Alzheimer's treatments - American Physical Therapy Association
New Law Allows Kansas Patients Direct Access to Physical Therapist Services - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
